Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 11.18 USD -0.45% Market Closed
Market Cap: 519m USD

Wall Street
Price Targets

AVNS Price Targets Summary
Avanos Medical Inc

There are no price targets for AVNS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Avanos Medical Inc Competitors:
Price Targets
SUPERMX
Supermax Corporation Bhd
22% Upside
AFME
Affluent Medical SAS
109% Upside
688289
Sansure Biotech Inc
40% Upside
300595
Autek China Inc
22% Upside
301122
Caina Technology Co Ltd
10% Upside
7741
Hoya Corp
9% Upside
8086
Nipro Corp
0% Downside
4549
Eiken Chemical Co Ltd
11% Downside

Revenue
Forecast

Revenue Estimate
Avanos Medical Inc

For the last 12 years the compound annual growth rate for Avanos Medical Inc's revenue is -7%. The projected CAGR for the next 3 years is 2%.

-7%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Avanos Medical Inc

For the last 12 years the compound annual growth rate for Avanos Medical Inc's operating income is -13%. The projected CAGR for the next 3 years is 51%.

-13%
Past Growth
51%
Estimated Growth
Estimates Accuracy
-59%
Average Miss

Net Income
Forecast

Net Income Estimate
Avanos Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVNS's stock price target?
Not Available

AVNS doesn't have any price targets made by Wall Street professionals.

What is Avanos Medical Inc's Revenue forecast?
Projected CAGR
2%

For the last 12 years the compound annual growth rate for Avanos Medical Inc's revenue is -7%. The projected CAGR for the next 3 years is 2%.

What is Avanos Medical Inc's Operating Income forecast?
Projected CAGR
51%

For the last 12 years the compound annual growth rate for Avanos Medical Inc's operating income is -13%. The projected CAGR for the next 3 years is 51%.

Back to Top